Elsawy M, Chavez JC, Avivi I, Larouche JF, et al. Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma. Blood 2022 Jul 15. pii: 485937. doi: 10.1182/blood.2022015478.
PMID: 35839452